Proof Lacking for Dual-Targeted Therapy Benefit in IBD Proof Lacking for Dual-Targeted Therapy Benefit in IBD
Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 27, 2023 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news

Food Additives May Exacerbate IBD Food Additives May Exacerbate IBD
Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 27, 2023 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news

Three Teenagers With Influenza Die After Secondary Infection Three Teenagers With Influenza Die After Secondary Infection
The deaths indicate an increase in serious diseases caused by secondary bacterial infections following an influenza A infection, according to the Robert Koch Institute.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 27, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

FDA Panel Backs Shift Toward One-Dose COVID Shot FDA Panel Backs Shift Toward One-Dose COVID Shot
The FDA ' s vaccine advisers lent support to the agency ' s plan to try to simplify future COVID shots, with an aim of having many people get just one dose in the fall.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 27, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Gesundheit! Allergies Affect More Than One in Four
(MedPage Today) -- More than a quarter of adults and children experienced some kind of allergic condition in 2021, according to two National Center for Health Statistics (NCHS) reports. The rate of 27.2% among children 17 years and under represented... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - January 27, 2023 Category: Allergy & Immunology Source Type: news

About 1 in 3 American Adults Has an Allergy
THURSDAY, Jan. 26, 2023 -- If it seems as though everyone you know struggles with some sort of allergy, new research suggests you are not mistaken. As many as 1 in 3 adults and 1 in 4 kids suffers from a seasonal allergy, a food allergy or eczema,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 26, 2023 Category: General Medicine Source Type: news

Something in Breast Milk Helps Protect Babies Against Allergies Something in Breast Milk Helps Protect Babies Against Allergies
Tiny molecules of microribonucleic acids (miRNAs) found in breast milk can help protect babies from developing allergic conditions like atopic dermatitis and food allergies.Quick Take (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 26, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
THURSDAY, Jan. 26, 2023 -- In two January data briefs published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics, data are presented regarding the prevalence of seasonal allergy, eczema, and food allergy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2023 Category: Pharmaceuticals Source Type: news

Africa: Even Bivalent Updated Covid-19 Boosters Struggle to Prevent Omicron Subvariant Transmission - an Immunologist Discusses Why New Approaches Are Necessary
[The Conversation Africa] By almost any measure, the vaccination campaign against SARS-CoV-2, the virus that causes COVID-19, has been a global success. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 26, 2023 Category: African Health Source Type: news

N.I.H. Did Not Properly Track a Group Studying Coronaviruses, Report Finds
An internal federal watchdog said that the health agency had not given adequate oversight to EcoHealth Alliance, which had been awarded $8 million in grants. (Source: NYT)
Source: NYT - January 26, 2023 Category: American Health Authors: Benjamin Mueller and Sheryl Gay Stolberg Tags: Coronavirus (2019-nCoV) United States Politics and Government Research Nonprofit Organizations Laboratories and Scientific Equipment EcoHealth Alliance National Institute of Allergy and Infectious Diseases National Institutes of Health Fau Source Type: news

The FDA Wants an Annual COVID Vaccine: What You Need to Know The FDA Wants an Annual COVID Vaccine: What You Need to Know
Is pivoting to an annual COVID-19 shot a smart move?WebMD Health News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 25, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

Q & A With Long COVID Patient, Researcher: Treatments Lagging Q & A With Long COVID Patient, Researcher: Treatments Lagging
The co-author of a new study on long COVID is also a long COVID patient. She shares her story as a patient and of her work to study its origins, what we know, and what we need to do.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 25, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

The Time Is Now to Curb Spring Allergies
WEDNESDAY, Jan. 25, 2023 -- Send yourself some love this Valentine ' s Day by setting a reminder to start taking your spring allergy medications. It ' s important to begin allergy meds two weeks before symptoms are expected to appear when possible,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 25, 2023 Category: General Medicine Source Type: news

Amazon launches $5-a-month unlimited prescription plan
Amazon is expanding its push into healthcare with a $5 monthly unlimited delivery pass on 60 common generic prescription drugs treating allergies, inflammation, high blood pressure and other conditions. Amazon announced the new delivery service, RXPass, on Tuesday and it will launch immediately in…#amazon #rxpass #minnesota #medicare #medicaid #amazonprime #evercore #elizabethanderson #seannicholson #cornelluniversity (Source: Reuters: Health)
Source: Reuters: Health - January 24, 2023 Category: Consumer Health News Source Type: news